Engineering Human Epidermal Growth Receptor 2-Targeting Hepatitis B Virus Core Nanoparticles for siRNA Delivery in Vitro and in Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering Human Epidermal Growth Receptor 2-Targeting Hepatitis B Virus Core Nanoparticles for siRNA Delivery in Vitro and in Vivo

Published:2018-06-20 Issue:7 Volume:1 Page:3269-3282
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Suffian Izzat F. M.¹,Wang Julie T.-W.¹,Faruqu Farid N.¹,Benitez Julio¹,Nishimura Yuya²,Ogino Chiaki²,Kondo Akihiko²^ORCID,Al-Jamal Khuloud T.¹^ORCID

Affiliation:

1. Institute of Pharmaceutical Science, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, U.K.

2. Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Japan

Funder

World Cancer Research Fund

Jabatan Perkhidmatan Awam Malaysia

Biotechnology and Biological Sciences Research Council

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

http://pubs.acs.org/doi/pdf/10.1021/acsanm.8b00480

Reference57 articles.

1. siRNA-based approaches in cancer therapy

2. Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications

3. Knocking down barriers: advances in siRNA delivery

4. Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi

5. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The advancement of siRNA-based nanomedicine for tumor therapy;Nanomedicine;2024-08-15

2. mRNA therapies: Pioneering a new era in rare genetic disease treatment;Journal of Controlled Release;2024-05

3. Engineering protein nanoparticles for drug delivery;Current Opinion in Biotechnology;2024-04

4. Novel Therapeutic Approaches for the Management of Hepatitis Infections;Therapeutic Delivery;2024-02-27

5. Virus-like particles (VLPs): A promising platform for combating against Newcastle disease virus;Vaccine: X;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3